DIALYSIS · CCN 852604

DaVita Bellemeade Dialysis

Smyrna, GA 30080

DialysisProfitDaVita
$3.0M
TOTAL REVENUE
25.4%
OPERATING MARGIN
3 / 5
STAR RATING
11
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.0M
Total costs
$2.2M
Operating income (rev − costs)
$753K
Operating margin
25.4%
Total charges
$2.9M
Total treatments
5,727
Dialysis stations
17

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

11 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
013—
Fistula Rate
DFC_FISTULA_RATE
56.442—
Five Star Rating
DFC_FIVE_STAR
3——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
132.226—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2042—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
1234—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
6.142—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
17.825—
Standardized ED Visits Ratio
DFC_SEDR
0.6112—